| Rodent models in neuroscience research: is it a rat race? B Ellenbroek, J Youn Disease models & mechanisms 9 (10), 1079-1087, 2016 | 724 | 2016 |
| Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus M Roceri, W Hendriks, G Racagni, BA Ellenbroek, MA Riva Molecular psychiatry 7 (6), 609-616, 2002 | 570 | 2002 |
| The effects of an early stressful life event on sensorimotor gating in adult rats BA Ellenbroek, PTJM van den Kroonenberg, AR Cools Schizophrenia research 30 (3), 251-260, 1998 | 320 | 1998 |
| Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system JR Homberg, JDA Olivier, BMG Smits, JD Mul, J Mudde, M Verheul, ... Neuroscience 146 (4), 1662-1676, 2007 | 301 | 2007 |
| Animal behavior models of the mechanisms underlying antipsychotic atypicality MA Geyer, B Ellenbroek Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (7), 1071-1079, 2003 | 297 | 2003 |
| A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders JDA Olivier, MGC Van Der Hart, RPL Van Swelm, PJ Dederen, ... Neuroscience 152 (3), 573-584, 2008 | 290 | 2008 |
| Search after neurobiological profile of individual-specific features of Wistar rats AR Cools, R Brachten, D Heeren, A Willemen, B Ellenbroek Brain research bulletin 24 (1), 49-69, 1990 | 283 | 1990 |
| Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex BA Ellenbroek, S Budde, AR Cools Neuroscience 75 (2), 535-542, 1996 | 244 | 1996 |
| Animal models with construct validity for schizophrenia BA Ellenbroek, AR Cools Behavioural pharmacology 1 (6), 469-490, 1990 | 243 | 1990 |
| Animal models for the negative symptoms of schizophrenia BA Ellenbroek, AR Cools Behavioural pharmacology 11 (3 & 4), 223-233, 2000 | 241 | 2000 |
| Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis BMG Smits, JB Mudde, J van de Belt, M Verheul, J Olivier, J Homberg, ... Pharmacogenetics and genomics 16 (3), 159-169, 2006 | 224 | 2006 |
| The histamine H3 receptor as a therapeutic drug target for CNS disorders MJ Gemkow, AJ Davenport, S Harich, BA Ellenbroek, A Cesura, D Hallett Drug discovery today 14 (9-10), 509-515, 2009 | 213 | 2009 |
| Role of cannabis and endocannabinoids in the genesis of schizophrenia E Fernandez-Espejo, MP Viveros, L Núñez, BA Ellenbroek, ... Psychopharmacology 206, 531-549, 2009 | 206 | 2009 |
| Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs BA Ellenbroek Pharmacology & therapeutics 57 (1), 1-78, 1993 | 177 | 1993 |
| The behavior of APO-SUS rats in animal models with construct validity for schizophrenia BA Ellenbroek, MA Geyer, AR Cools Journal of Neuroscience 15 (11), 7604-7611, 1995 | 170 | 1995 |
| Early maternal deprivation and prepulse inhibition: the role of the postdeprivation environment BA Ellenbroek, AR Cools Pharmacology Biochemistry and Behavior 73 (1), 177-184, 2002 | 160 | 2002 |
| Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit F Streijger, F Oerlemans, BA Ellenbroek, CR Jost, B Wieringa, ... Behavioural brain research 157 (2), 219-234, 2005 | 146 | 2005 |
| Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans R Molteni, A Cattaneo, F Calabrese, F Macchi, JDA Olivier, G Racagni, ... Neurobiology of disease 37 (3), 747-755, 2010 | 139 | 2010 |
| The long-term effects of maternal deprivation depend on the genetic background BA Ellenbroek, AR Cools Neuropsychopharmacology 23 (1), 99-106, 2000 | 138 | 2000 |
| Apomorphine susceptibility and animal models for psychopathology: genes and environment BA Ellenbroek, AR Cools Behavior genetics 32, 349-361, 2002 | 137 | 2002 |
